4//SEC Filing
GARNICK MARC B 4
Accession 0001033025-04-000006
CIK 0001033025other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 11:07 AM ET
Size
8.7 KB
Accession
0001033025-04-000006
Insider Transaction Report
Form 4
GARNICK MARC B
EVP and Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock, par value $.01 per share
2004-02-09$0.27/sh+52,499$14,175→ 460,221 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-02-09−52,499→ 0 totalExercise: $0.27From: 2004-02-09Exp: 2006-07-11→ Common Stock, par value $.01 per share (52,499 underlying)
Holdings
- 36,000(indirect: By Trust)
Common Stock, par value $.01 per share
- 25,270(indirect: By Trust)
Common Stock, par value $.01 per share
Footnotes (1)
- [F1]The term of the option is ten years from the date of grant.
Documents
Issuer
PRAECIS PHARMACEUTICALS INC
CIK 0001033025
Entity typeother
Related Parties
1- filerCIK 0001215549
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 11:07 AM ET
- Size
- 8.7 KB